Long-term follow-up of perifoveal exudative vascular anomalous complex treated with intravitreal injections of anti-vascular endothelial growth factor and thermal laser photocoagulation

Querques G, Kuhn D, Massamba N, Leveziel N, Querques L, Souied EH. Perifoveal exudative vascular anomalous complex. J Fr Ophtalmol. 34(8):559.e1-559.e4. Sacconi, 2017, The expanded spectrum of perifoveal exudative vascular anomalous complex, Am J Ophthalmol, 184, 137, 10.1016/j.ajo.2017.10.009 Mrejen, 2020, Insights into perifoveal exudative vascular anomalous complex, Retina, 40, 80, 10.1097/IAE.0000000000002435 Zhang, 2019, Case report: perifoveal exudative vascular anomalous complex in a Chinese patient with diabetes mellitus, Optom Vis Sci, 96, 531, 10.1097/OPX.0000000000001401 Venkatesh, 2019, Multimodal imaging in perifoveal exudative vascular anomalous complex with Co-existent diabetic retinopathy, Clin Exp Optom, 102, 528, 10.1111/cxo.12868 Sacconi, 2020, Non-exudative perifoveal vascular anomalous complex: the sub-clinical stage of perifoveal exudative vascular anomalous complex?, Am J Ophthalmol, S0002-9394, 30193 Sacconi, 2018, Nascent type 3 neovascularization in age-related macular degeneration, Ophthalmol Retina, 2, 1097, 10.1016/j.oret.2018.04.016 Siedlecki, 2019, Lamellar hole-associated epiretinal proliferation presenting with perifoveal exudative vascular anomalous complex, Am J Ophthalmol Case Rep, 14, 112, 10.1016/j.ajoc.2019.03.008